After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Nuvation Bio Inc is listed on the NYSE in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Nuvation Bio Inc is $2.95B. A total of 5.42 million shares were traded on the day, compared to an average of 8.34M shares.
In the most recent transaction, Liu Dongfang sold 150,000 shares of NUVB for 7.82 per share on Dec 01 ’25. After the transaction, the CHIEF MEDICAL OFFICER now owns 18,000 company shares. In a previous transaction on Dec 01 ’25, DONGFANG LIU bought 150,000 shares at 7.82 per share.
Among the insiders who sold shares, Liu Dongfang disposed of 10,000 shares on Nov 26 ’25 at a per-share price of $8.00. This resulted in the CHIEF MEDICAL OFFICER holding 18,000 shares of NUVB after the transaction. In another insider transaction, Liu Dongfang sold 10,000 shares at $7.50 per share on Nov 25 ’25. Company shares held by the CHIEF MEDICAL OFFICER now total 18,000.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NUVB has a high of $9.75 and a low of $1.54.
As of this writing, NUVB has an earnings estimate of -$0.04 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.04. The company reported an EPS of -$0.12 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NUVB’s latest balance sheet shows that the firm has $765.39M in Cash & Short Term Investments as of fiscal 2021. There were $3.06M in debt and $16.93M in liabilities at the time. Its Book Value Per Share was $0.95, while its Total Shareholder’s Equity was $746.00M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NUVB is Buy with a score of 4.73.
